Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
5.80    -0.10 (-1.69%)
Bid:
5.70
Ask:
5.90
Spread: 0.20 (3.509%)
Market Cap: £14.92m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

Lucyd Pte Ltd. Update

4 Jul 2018 07:00

RNS Number : 4692T
Tekcapital plc
04 July 2018
 

4 July 2018

Tekcapital plc

("Tekcapital" or the "Company")

 

Lucyd Pte Ltd. Appoints Dr Ira A. Clement as Science Advisor and

Files New Patent Application

 

Tekcapital plc (AIM: TEK), the UK intellectual property (IP) investment group focused on creating marketplace value from university technology, is pleased to announce that Lucyd Pte Ltd ("Lucyd") has appointed Dr Ira A. Clement, a licensed optometrist, as a science advisor and that it has filed a new patent application.

 

New appointment

 

Dr. Clement has over 40 years of experience in the practice of optometry. He has served as Past-President of the Westchester-Rockland-Putnam Optometric Society. As part of his pro bono activities, Dr Clement served as Past-President of the Suffern LIONS Club. Since its founding in 1917, Lions Clubs International® has worked on projects designed to prevent blindness, restore eyesight and improve eye health and eye care for hundreds of millions of people worldwide.

 

New Patent Application

 

On 2 July 2018, Lucyd announced the filing of a patent application No. 16/022,097 to improve the utility of Augmented Reality ("AR") glasses. The application is directed to smartglasses, with prescription lenses, and methods to control the presentation and display of information related to mobile device tasks that can be performed with these smartglasses.

 

Lucyd is delighted that Dr. Clement has joined the company's science advisory board. As a highly experienced optometrist, they believe their customers can benefit from his knowledgeable answers to questions regarding eye health. Additionally, Lucyd believes the new patent application may significantly enhance the ergonomics of AR glasses while maintaining a transparent interface.

 

Lucyd Pte Ltd is developing ergonomic smartglasses, blockchain apps and an eyewear e-shop to enhance the visual experience. To learn more about Lucyd, please visit www.lucyd.co.

 

Lucyd Pte Ltd is a subsidiary of Lucyd ltd, a Tekcapital portfolio company. Lucyd ltd is wholly owned by Tekcapital plc.

 

For further information please contact:

 

Tekcapital plc

Clifford M Gross, Ph.D.

 

Via Walbrook PR

 

finnCap Ltd (Nominated Adviser and Joint Broker)

+ 44 (0) 20 7220 0500

Geoff Nash / Max Bullen-Smith (Corporate Finance)

Alice Lane (ECM)

 

Dowgate Capital Stockbrokers (Joint Broker)

+44 (0) 1293 517744

David Poutney / James Serjeant

 

Walbrook PR Ltd

+44 (0) 20 7933 8780

Paul Cornelius / Sam Allen / Nick Rome

tekcapital@walbrookpr.com

 

Tekcapital plc - The World's Largest University Network for Open Innovation

 

Tekcapital's objective is to create value from investing in new, university-developed intellectual properties. Additionally, using its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a range of IP investment services to make it easy for organisations to find, evaluate, acquire and license university-developed technology. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

LEI: 213800GOJTOV19FIFZ85

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAXXLFBVDFZBBF
Date   Source Headline
25th May 20227:00 amRNSPlacing to Raise £2 Million (c.US$ 2.5M)
6th May 202211:36 amRNSNotice of AGM
6th May 20227:00 amRNSFinal Year End Record Results
5th May 20227:00 amRNSGuident Update
3rd May 20228:35 amRNSGuident Update
19th Apr 20227:00 amRNSPortfolio Company Update - Guident
1st Apr 20227:00 amRNSPortfolio Company Update - Salarius
25th Mar 202211:39 amRNSNotification of Major Holdings
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSSalarius Update
11th Feb 20225:58 pmRNSExercise of Stock Options and Total Voting Rights
11th Feb 20222:06 pmRNSSecond Price Monitoring Extn
11th Feb 20222:00 pmRNSPrice Monitoring Extension
11th Feb 202211:06 amRNSSecond Price Monitoring Extn
11th Feb 202211:01 amRNSPrice Monitoring Extension
4th Feb 20227:00 amRNSGuident Update
2nd Feb 20227:00 amRNSLucyd Expands Ecommerce Channels
4th Jan 20227:00 amRNSSalarius Completes Oversubscribed Crowdfund
29th Dec 20217:00 amRNSSalarius Appoints CEO
24th Dec 20217:00 amRNSSalarius Appoints Non Executive Director
14th Dec 20217:00 amRNSLucyd Filing for United States IPO
9th Dec 20217:00 amRNSSalarius Update
22nd Nov 202112:09 pmRNSHolding(s) in Company
16th Nov 20217:00 amRNSSalarius Update
15th Nov 20217:00 amRNSSalarius Update
11th Nov 20217:00 amRNSAppointment of new Auditor
4th Nov 20217:00 amRNSPortfolio Company Update: Lucyd Ltd ("Lucyd")
3rd Nov 20217:00 amRNSPlacing to raise £3.0 million
27th Oct 20217:00 amRNSSalarius Appointment of Chief Medical Officer
26th Oct 20214:40 pmRNSSecond Price Monitoring Extn
26th Oct 20214:35 pmRNSPrice Monitoring Extension
26th Oct 202111:05 amRNSSecond Price Monitoring Extn
26th Oct 202111:00 amRNSPrice Monitoring Extension
19th Oct 20218:00 amRNSLucyd Proposed IPO in the United States
19th Oct 20217:00 amRNSLucyd Update
14th Oct 202111:05 amRNSSecond Price Monitoring Extn
14th Oct 202111:00 amRNSPrice Monitoring Extension
14th Oct 20217:00 amRNSSalarius FDA Sodium Reduction Goals
8th Oct 20218:59 amRNSSaltMe Roll out in leading US Supermarket Chain
29th Sep 20212:17 pmRNSLucyd Distribution Growth
20th Sep 20214:41 pmRNSSecond Price Monitoring Extn
20th Sep 20214:36 pmRNSPrice Monitoring Extension
10th Sep 202111:30 amRNSNotification of Major Shareholding
31st Aug 20217:00 amRNSLucyd Update
24th Aug 20217:00 amRNSLucyd Non Executive Director Appointment
20th Aug 20219:05 amRNSSecond Price Monitoring Extn
20th Aug 20219:00 amRNSPrice Monitoring Extension
16th Aug 20217:00 amRNSRecord Half Year Results for period to 31 May 2021
5th Aug 20212:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.